• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Ra Medical Systems Inc.

    3/31/23 4:15:34 PM ET
    $RMED
    Medical/Dental Instruments
    Health Care
    Get the next $RMED alert in real time by email
    SC 13G 1 tm2310993d1_sc13g.htm SC 13G

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

     

    Ra Medical Systems, Inc.
    (Name of Issuer)
     
    Common Stock, $0.0001 Par Value
    (Title of Class of Securities)
     
    74933X302
    (CUSIP Number)
     
    W. Keith Wilkes, Jr.
    c/o RFA Management Company, LLC
    1908 Cliff Valley Way N.E.
    Atlanta, GA 30329
     
    with a copy to:
    Eric Orsic
    McDermott Will & Emery LLP
    444 West Lake Street, Suite 4000
     Chicago, IL 60606
    (312) 372-2000
    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
     
    March 21, 2023
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    a. ¨ Rule 13d-1(b)
    b. x Rule 13d-1(c)
    c. ¨ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    1. Names of Reporting Persons.
       
      Gary W. Rollins Voting Trust U/A dated September 14, 1994
       
    2. Check the Appropriate Box if a Member of a Group (See Instructions)
       
      (a) x
      (b) ¨
       
    3. SEC Use Only
       
    4.

    Citizenship or Place of Organization         

    United States

       

     

    Number of
    Shares Beneficially
    Owned by Each
    Reporting
    Person With:
    5. Sole Voting Power 0
         
         
      6. Shared Voting Power 261,553 (1)
         
      7. Sole Dispositive Power 0
         
      8. Shared Dispositive Power 261,553 (1)
         

     

    9. Aggregate Amount Beneficially Owned by Each Reporting Person 
       
      261,553 (1)
       
    10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)                          
       
    11. Percent of Class Represented by Amount in Row (9)          5.25%
       
    12. Type of Reporting Person (See Instructions)
       
      OO

     

    (1)       Includes 261,553 shares of Common Stock held by RFT Investment Company, LLC. The Gary W. Rollins Voting Trust U/A dated September 14, 1994 (the “GWR Voting Trust”) has a 50% voting interest in LOR, Inc., which is the manager of RFT Investment Company, LLC. Does not include 1,165,949 shares of Common Stock that may be issued upon conversion of 1,165.949 shares of Series X Preferred Stock held by RFT Investment Company LLC which may not be converted, at the earliest, until July 9, 2024. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person’s pecuniary interest.

     

     

     

     

    1. Names of Reporting Persons.
       
      R. Randall Rollins Voting Trust U/A dated August 25, 1994
       
    2. Check the Appropriate Box if a Member of a Group (See Instructions)
       
      (a) x
      (b) ¨
       
    3. SEC Use Only
       
    4.

    Citizenship or Place of Organization         

    United States

       

     

    Number of
    Shares Beneficially
    Owned by Each
    Reporting
    Person With:
    5. Sole Voting Power 0
         
         
      6. Shared Voting Power 261,553 (1)
         
      7. Sole Dispositive Power 0
         
      8. Shared Dispositive Power 261,553 (1)
         

     

    9. Aggregate Amount Beneficially Owned by Each Reporting Person 
       
      261,553 (1)
       
    10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)                          
       
    11. Percent of Class Represented by Amount in Row (9)          5.25%
       
    12. Type of Reporting Person (See Instructions)
       
      OO

     

    (1)       Includes 261,553 shares of Common Stock held by RFT Investment Company, LLC. The R. Randall Rollins Voting Trust U/A dated August 25, 1994 (the “RRR Voting Trust”) has a 50% voting interest in LOR, Inc., which is the manager of RFT Investment Company, LLC. Does not include 1,165,949 shares of Common Stock that may be issued upon conversion of 1,165.949 shares of Series X Preferred Stock held by RFT Investment Company LLC which may not be converted, at the earliest, until July 9, 2024. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person’s pecuniary interest.

     

     

     

     

    1. Names of Reporting Persons.
       
      LOR, Inc.
       
    2. Check the Appropriate Box if a Member of a Group (See Instructions)
       
      (a) x
      (b) ¨
       
    3. SEC Use Only
       
    4.

    Citizenship or Place of Organization         

    Georgia

       

    ]

    Number of
    Shares Beneficially
    Owned by Each
    Reporting
    Person With:
    5. Sole Voting Power 0
         
         
      6. Shared Voting Power 261,553 (1)
         
      7. Sole Dispositive Power 0
         
      8. Shared Dispositive Power 261,553 (1)
         

     

    9. Aggregate Amount Beneficially Owned by Each Reporting Person   
       
      261,553 (1)
       
    10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)                          
       
    11. Percent of Class Represented by Amount in Row (9)          5.25%
       
    12. Type of Reporting Person (See Instructions)
       
      CO

     

    (1)       Includes 261,553 shares of Common Stock held by RFT Investment Company, LLC. LOR, Inc. is the manager of RFT Investment Company, LLC. Does not include 1,165,949 shares of Common Stock that may be issued upon conversion of 1,165.949 shares of Series X Preferred Stock held by RFT Investment Company LLC which may not be converted, at the earliest, until July 9, 2024. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person’s pecuniary interest.

     

     

     

     

    1. Names of Reporting Persons.
       
      RFT Investment Company, LLC
       
    2. Check the Appropriate Box if a Member of a Group (See Instructions)
       
      (a) x
      (b) ¨
       
    3. SEC Use Only
       
    4.

    Citizenship or Place of Organization         

    Georgia

       

     

    Number of
    Shares Beneficially
    Owned by Each
    Reporting
    Person With:
    5. Sole Voting Power 261,553 (1)
         
         
      6. Shared Voting Power 0
         
      7. Sole Dispositive Power 261,553 (1)
         
      8. Shared Dispositive Power 0
         

     

    9. Aggregate Amount Beneficially Owned by Each Reporting Person   
       
      261,553
       
    10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)                          
       
    11. Percent of Class Represented by Amount in Row (9)          5.25%
       
    12. Type of Reporting Person (See Instructions)
       
      OO

     

    (1)       Does not include 1,165,949 shares of Common Stock that may be issued upon conversion of 1,165.949 shares of Series X Preferred Stock held by RFT Investment Company LLC which may not be converted, at the earliest, until July 9, 2024. The reporting person disclaims beneficial ownership of these shares except to the extent of the reporting person’s pecuniary interest.

     

     

     

     

    Item 1(a). Name of Issuer:

     

    Ra Medical Systems, Inc. (the “Issuer”)

     

    Item 1(b). Address of Issuer’s Principal Executive Offices:

     

    1670 Highway 160 West

    Suite 205

    Fort Mill, SC 29708 

     

    Item 2(a). Name of Person Filing:

     

    Gary W. Rollins Voting Trust U/A dated September 14, 1994 (the “GWR Voting Trust”)

    R. Randall Rollins Voting Trust U/A dated August 25, 1994 (the “RRR Voting Trust”)

    LOR, Inc.

    RFT Investment Company, LLC

     

    Item 2(b). Address of Principal Business Offices or, if none, Residence:

     

    GWR Voting Trust

    c/o RFA Management Company, LLC

    1908 Cliff Valley Way, NE

    Atlanta, Georgia 30329

     

     

    RRR Voting Trust

    c/o RFA Management Company, LLC

    1908 Cliff Valley Way, NE

    Atlanta, Georgia 30329

     

    LOR, Inc.

    c/o RFA Management Company, LLC

    1908 Cliff Valley Way, NE

    Atlanta, Georgia 30329

     

     

    RFT Investment Company, LLC

    c/o RFA Management Company, LLC

    1908 Cliff Valley Way, NE

    Atlanta, Georgia 30329

     

    Item 2(c). Citizenship:

     

    GWR Voting Trust – United States

    RRR Voting Trust – United States

    LOR, Inc. – Georgia

    RFT Investment Company, LLC – Georgia

     

    Item 2(d). Title of Class of Securities:

     

    Common Stock, $0.0001 Par Value

     

    Item 2(e). CUSIP Number:

     

    74933X302

     

     

     

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    Not applicable.

      

    Item 4. Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a), (b), and (c):

     

    The information as of the date of the event which requires filing of this statement required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page for the Reporting Person hereto and is incorporated herein by reference. The percentage set forth in Row 11 of the cover page for the Reporting Person is based on 4,984,093 shares of the Common Stock issued and outstanding as of March 23, 2023 as reported in the Issuer’s Form 10-K for the fiscal year ended December 31, 2022 filed with the Securities and Exchange Commission on March 28, 2023.

      

    Item 5.    Ownership of Five Percent or Less of a Class.

     

    Not applicable.

     

    Item 6.    Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

     

    Not applicable

     

    Item 8.    Identification and Classification of Members of the Group.

     

    Not applicable

     

    Item 9.    Notice of Dissolution of Group.

     

    Not applicable

     

    Item 10. Certification

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

     

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    By: /s/ TIMOTHY C. ROLLINS   Date: March 31, 2023
      TIMOTHY C. ROLLINS    
           
      As Co-Trustee of the R. RANDALL ROLLINS VOTING TRUST U/A DATED AUGUST 25, 1994, and
      As Co-Trustee of the GARY W. ROLLINS VOTING TRUST U/A DATED SEPTEMBER 14, 1994, and
           
      As Vice President of    
      LOR, INC., and    
           
      As Vice President of LOR, Inc., in its capacity as Manager of    
      RFT INVESTMENT COMPANY, LLC    
           

     

     

     

     

    EXHIBIT A

     

    Joint Filing Agreement

     

    In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, each of the persons named below agrees to the joint filing of this Amendment to Schedule 13G, including further amendments thereto, with respect to the shares of Common Stock, $0.0001 par value per share, of Ra Medical Systems, Inc. and further agrees that this Joint Filing Agreement be filed with the Securities and Exchange Commission as an exhibit to such filing; provided, however, that no person shall be responsible for the completeness or accuracy of the information concerning the other persons making the filing unless such person knows or has reason to believe such information is inaccurate (as provided in Rule 13d-1(k)(1)(ii)). This Joint Filing Agreement may be executed in one or more counterparts, all of which together shall constitute one and the same instrument.

    IN WITNESS WHEREOF, the persons named below have executed this Joint Filing Agreement as of the date set forth below.

     

    By: /s/ TIMOTHY C. ROLLINS   Date: March 31, 2023
      TIMOTHY C. ROLLINS    
           
      As Co-Trustee of the R. RANDALL ROLLINS VOTING TRUST U/A DATED AUGUST 25, 1994, and
      As Co-Trustee of the GARY W. ROLLINS VOTING TRUST U/A DATED SEPTEMBER 14, 1994, and
           
      As Vice President of    
      LOR, INC., and    
           
      As Vice President of LOR, Inc., in its capacity as Manager of    
      RFT INVESTMENT COMPANY, LLC    
           

     

     

    Get the next $RMED alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $RMED

    DatePrice TargetRatingAnalyst
    10/21/2021$12.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $RMED
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Reminder: Ra Medical Systems Announces Name and Ticker Symbol Changes

      Name change to Catheter Precision, Inc. is effective on August 17, 2023, with trading under new ticker symbol VTAK to begin on August 18, 2023FORT MILL, SC / ACCESSWIRE / August 17, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) announced that its Board of Directors has approved changing the Company's corporate name to "Catheter Precision, Inc." The effective date of the name change is today, August 17, 2023. The Company has reserved the ticker symbol "VTAK" with the NYSE American, and the Company's common stock is expected to begin trading on the NYSE American under its new name and the new trading symbol effective as of the market open on August 18, 2023. The Company's new website will be unv

      8/17/23 8:00:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems Announces Allowance of New Closure Device Patent

      First patent out of six applications on file for LockeT productFORT MILL, SC / ACCESSWIRE / August 14, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) today announced that it has received notification of allowance of the first patent to be issued for the company's LockeT product. Entitled "Vessel Closing Device", the patent to be granted is one in a family of six patent applications on file in the US, and in a number of foreign countries, including the European Community, Japan, and China.David Jenkins, interim CEO of Ra Medical Systems, commented, "We are pleased to see the first of what should be several patents to come about with the LockeT closure device. It is a clever design and invention,

      8/14/23 8:00:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems Announces Milestone Achievement for Electrophysiology Division

      Catheter Precision's VIVO System Has Been Utilized in over 1,000 ProceduresFORT MILL, SC / ACCESSWIRE / August 7, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) announced today that VIVO, the lead product for the electrophysiology division, has been used in more than 1000 ventricular ablation procedures. VIVO, which stands for View Into Ventricular Onset, enables physicians to learn more about patient specific anatomy and better help them plan the ablation procedure. As a result, VIVO aids in reducing overall procedure time benefitting physicians, hospitals and patients."I made a conscious decision to support a pre-commercial roll out with my own capital. I've invested well over $25mm at an ave

      8/7/23 8:00:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    SEC Filings

    See more
    • Ra Medical Systems Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities

      8-K - Catheter Precision, Inc. (0001716621) (Filer)

      1/25/24 4:15:50 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Catheter Precision, Inc. (0001716621) (Filer)

      1/11/24 4:15:46 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems Inc. filed SEC Form 8-K: Leadership Update

      8-K - Catheter Precision, Inc. (0001716621) (Filer)

      1/4/24 4:20:59 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Jenkins David A bought $9,786 worth of shares (19,056 units at $0.51), increasing direct ownership by 6% to 329,856 units (SEC Form 4)

      4 - Catheter Precision, Inc. (0001716621) (Issuer)

      1/24/24 4:15:18 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Jenkins David A bought $7,086 worth of shares (16,940 units at $0.42), increasing direct ownership by 6% to 310,800 units (SEC Form 4)

      4 - Catheter Precision, Inc. (0001716621) (Issuer)

      1/22/24 4:15:35 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Jenkins David A bought $6,323 worth of shares (16,263 units at $0.39), increasing direct ownership by 6% to 293,860 units (SEC Form 4)

      4 - Catheter Precision, Inc. (0001716621) (Issuer)

      1/18/24 4:15:33 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HC Wainwright & Co. initiated coverage on Ra Medical Systems with a new price target

      HC Wainwright & Co. initiated coverage of Ra Medical Systems with a rating of Buy and set a new price target of $12.00

      10/21/21 6:17:16 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems downgraded by Maxim Group

      Maxim Group downgraded Ra Medical Systems from Buy to Hold

      3/17/21 8:31:51 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Jenkins David A bought $9,786 worth of shares (19,056 units at $0.51), increasing direct ownership by 6% to 329,856 units (SEC Form 4)

      4 - Catheter Precision, Inc. (0001716621) (Issuer)

      1/24/24 4:15:18 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Jenkins David A bought $7,086 worth of shares (16,940 units at $0.42), increasing direct ownership by 6% to 310,800 units (SEC Form 4)

      4 - Catheter Precision, Inc. (0001716621) (Issuer)

      1/22/24 4:15:35 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Jenkins David A bought $6,323 worth of shares (16,263 units at $0.39), increasing direct ownership by 6% to 293,860 units (SEC Form 4)

      4 - Catheter Precision, Inc. (0001716621) (Issuer)

      1/18/24 4:15:33 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    Leadership Updates

    Live Leadership Updates

    See more
    • Ra Medical Systems Announces First Quarter Results

      FORT MILL, SC / ACCESSWIRE / June 2, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) today announced financial and company highlights for the first quarter ended March 31,2023. Among the quarter highlights are the following:RMED concluded the acquisition with the private, company Catheter Precision, Inc. ("Catheter"), in January 2023. Catheter is in the MedTech space of cardiac electrophysiology.Catheter onboarded five direct salespersons and several field clinical persons to assist in the broad US launch of its VIVO product, a product utilized to non-invasively determine the source, or earliest activation, of a ventricular arrhythmia.Catheter introduced to the market its new LockeT closure devi

      6/2/23 6:35:00 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Announces Resignation of CEO

      Board Committee Seeking ReplacementFORT MILL, SC / ACCESSWIRE / April 18, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) announced today the resignation of its CEO, Will McGuire, for personal reasons. The resignation will be effective April 28, 2023. In conjunction with his resignation as CEO, Mr. McGuire is also resigning from the RMED board of directors. The Company thanks Mr. McGuire for his service and contributions and wishes him the best in future endeavors.The RMED board of directors, as part of its governance commitment, last month established a committee for examining a transition at the CEO level. Mr. David Jenkins, the Company's Executive Chairman of the Board, will serve as Interim

      4/18/23 8:00:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems Announces Change in Chief Financial Officer Position Previous Acting CFO Position Replaced with Permanent Appointment

      FORT MILL, SC / ACCESSWIRE / March 30, 2023 / Ra Medical Systems, Inc. (NYSE:RMED) today announced the appointment of Steven Passey as Chief Financial Officer effective April 1, 2023, replacing Brian Conn, who has been serving as Acting Chief Financial Officer."Steven joins the executive team at a pivotal time in Ra Medical's growth", stated Ra Medical's Executive Chairman of the Board David Jenkins. "His background with publicly traded companies, budget and cost control ensures we will maintain the highest standards as a public company. In addition, he is a seasoned executive who has led M&A transactions as well as numerous equity and debt financing transactions for strategic growth. His ex

      3/30/23 7:30:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    Financials

    Live finance-specific insights

    See more
    • Ra Medical Systems Announces Date of Special Shareholder Meeting

      FORT MILL, SC / ACCESSWIRE / February 10, 2023 / Ra Medical Systems (NYSE:RMED) today announced the date of March 21, 2023 as the date of its special shareholder meeting. Shareholders of record as of February 3, 2023 are entitled to vote at the meeting.Among other items, shareholders are requested to vote in favor of a previously announced $8 million private financing, and to vote in favor of the conversion of RMED preferred stock into common stock, the majority of which will not be converted until mid-2024, at the earliest. The preferred stock was issued in connection with the acquisition of Catheter Precision, Inc., earlier this year.About Ra Medical SystemsRa Medical, and its wholly owned

      2/10/23 9:20:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022

      Ra Medical Systems, Inc. (NYSE:RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday, May 16. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update. Pre-Registration   Participants can pre-register for the conference call here:           Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.

      5/9/22 6:50:00 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results

      Conference call begins at 4:30 p.m. Eastern time today Ra Medical Systems, Inc. (NYSE:RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months and full year ended December 31, 2021 and provides a business update. Recent Operational Highlights Filed 510(k) application with the FDA for our next-generation DABRA catheter that incorporates a braided overjacket designed to improve robustness and includes data supporting a six-month shelf life Enrolled 13 subjects in the company's atherectomy pivotal clinical study since mid-November 2021, for a total of 98 subjects enrolled, and received approv

      3/23/22 4:05:00 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care

    $RMED
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Ra Medical Systems Inc.

      SC 13G - Catheter Precision, Inc. (0001716621) (Subject)

      2/14/24 3:57:22 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D/A filed by Ra Medical Systems Inc. (Amendment)

      SC 13D/A - Catheter Precision, Inc. (0001716621) (Subject)

      1/16/24 8:15:49 AM ET
      $RMED
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Ra Medical Systems Inc.

      SC 13G - Ra Medical Systems, Inc. (0001716621) (Subject)

      3/31/23 4:15:34 PM ET
      $RMED
      Medical/Dental Instruments
      Health Care